Nikola Zagorec, Department of Nephrology and Dialysis, Dubrava University Hospital, Avenija Gojka Šuška 6, 10000 Zagreb, Croatia,
Croat Med J. 2022 Aug 31;63(4):389-393. doi: 10.3325/cmj.2022.63.389.
Since the beginning of mass vaccination against coronavirus disease 2019 (COVID-19), vaccine-linked immune-mediated diseases have been increasingly reported. The development of these diseases after COVID-19 vaccination may be attributed to the mechanisms of molecular mimicry and cross-reactivity between the viral spike protein and self-antigens. The most frequent vaccine-linked glomerular disease is immunoglobulin A nephropathy (IgAN). Cutaneous vasculitis has also been reported after COVID-19 vaccination. In both diseases, deposition of immune complexes activates the inflammatory response with end-organ damage. We report on a case of de novo IgAN in a young man and a case of severe cutaneous vasculitis in a 68-year-old woman, both after the second dose of Pfizer-BioNTech COVID-19 vaccine. Neither of the patients had a history of autoimmunity or adverse reactions to vaccines. The temporal association between vaccination and disease development in the absence of other possible intercurrent inciting events suggests a causal mechanism, although coincidental co-occurrence cannot be excluded. In both cases, immunosuppressive treatment was warranted to stop disease progression and to partially or completely resolve the disease. A timely reaction is needed if new-onset signs of an immune-mediated disease appear after vaccination.
自 2019 年冠状病毒病(COVID-19)大规模疫苗接种开始以来,与疫苗相关的免疫介导性疾病的报道日益增多。COVID-19 疫苗接种后这些疾病的发展可能归因于病毒刺突蛋白和自身抗原之间的分子模拟和交叉反应机制。与疫苗相关的最常见肾小球疾病是免疫球蛋白 A 肾病(IgAN)。COVID-19 疫苗接种后也有皮肤血管炎的报道。在这两种疾病中,免疫复合物的沉积激活炎症反应并导致靶器官损伤。我们报告了一例年轻男性接种辉瑞-生物技术公司第二剂 COVID-19 疫苗后出现新发 IgAN,以及一例 68 岁女性接种辉瑞-生物技术公司第二剂 COVID-19 疫苗后出现严重皮肤血管炎。这两名患者均无自身免疫病史或疫苗不良反应史。在没有其他可能的并发诱发事件的情况下,疫苗接种和疾病发展之间的时间关联提示存在因果机制,但不能排除偶发的同时发生。在这两种情况下,均需要进行免疫抑制治疗以阻止疾病进展并部分或完全缓解疾病。如果在接种疫苗后出现新的免疫介导性疾病迹象,需要及时做出反应。